Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Yilmaz

Showing results (191-200 of 194) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 194 results.
The New England Journal of Medicine|November 13, 2020
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
European Journal of Heart Failure|September 28, 2020
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trialsJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
The New England Journal of Medicine|August 22, 2019
Effects of Serelaxin in Patients with Acute Heart FailureMarco Metra, John R Teerlink, Gad Cotter, et al.
Circulation. Heart Failure|July 8, 2018
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF TrialScott D Solomon, Adel R Rizkala, Martin P Lefkowitz, et al.
Pageof 20

Showing results (191-200 of 194) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 194 results.
The New England Journal of Medicine|November 13, 2020
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
European Journal of Heart Failure|September 28, 2020
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trialsJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
The New England Journal of Medicine|August 22, 2019
Effects of Serelaxin in Patients with Acute Heart FailureMarco Metra, John R Teerlink, Gad Cotter, et al.
Circulation. Heart Failure|July 8, 2018
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF TrialScott D Solomon, Adel R Rizkala, Martin P Lefkowitz, et al.
Pageof 20